Angiogenesis as a target for cancer therapy (Q35038768)

5 August 2017

1 reference

title

Angiogenesis as a target for cancer therapy (English)

1 reference

5 August 2017

2

Roy S Herbst

1 reference

5 August 2017

Kerim Kaban

1

1 reference

5 August 2017

publication date

1 October 2002

1 reference

Hematology / Oncology Clinics of North America

5 August 2017

published in

1 reference

5 August 2017

volume

16

1 reference

5 August 2017

issue

5

1 reference

5 August 2017

page(s)

1125-1171

1 reference

Angiogenesis in cancer, vascular, rheumatoid and other disease

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Angiogenesis in cancer and other diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Tumor angiogenesis: therapeutic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Initial stages of tumor cell-induced angiogenesis: evaluation via skin window chambers in rodent models

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

The regulation of neovascularization of matrix metalloproteinases and their inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Integrins in vascular development

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

The ephrins and Eph receptors in angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Increased vascularization in mice overexpressing angiopoietin-1

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Lymphatic endothelium: a new frontier of metastasis research

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

How tumors become angiogenic

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Expression of vascular endothelial growth factor and its receptors in multiple myeloma and other hematopoietic malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

FGF and VEGF function in angiogenesis: signalling pathways, biological responses and therapeutic inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Thrombospondin-1, vascular endothelial growth factor and fibroblast growth factor-2 are key functional regulators of angiogenesis in the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Influence of angiogenetic factors and matrix metalloproteinases upon tumour progression in non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

A human fibrosarcoma inhibits systemic angiogenesis and the growth of experimental metastases via thrombospondin-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

The role of vascular endothelial growth factor in angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Angiostatin induces endothelial cell apoptosis and activation of focal adhesion kinase independently of the integrin-binding motif RGD.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Stabilization of vascular endothelial growth factor mRNA by hypoxia-inducible factor 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

von Hippel Lindau tumor suppressor and HIF-1alpha: new targets of NSAIDs inhibition of hypoxia-induced angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Synergistic cooperation between hypoxia and transforming growth factor-beta pathways on human vascular endothelial growth factor gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Hypoxia augments cytokine (transforming growth factor-beta (TGF-beta) and IL-1)-induced vascular endothelial growth factor secretion by human synovial fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Vascular endothelial growth factor and its receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Molecular angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Vascular endothelial growth factor upregulates the expression of matrix metalloproteinases in vascular smooth muscle cells: role of flt-1

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Vascular endothelial growth factor modulates the Tie-2:Tie-1 receptor complex.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

VEGF increases permeability of the endothelial cell monolayer by activation of PKB/akt, endothelial nitric-oxide synthase, and MAP kinase pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Retinal vascular endothelial growth factor induces intercellular adhesion molecule-1 and endothelial nitric oxide synthase expression and initiates early diabetic retinal leukocyte adhesion in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

VEGF165 mediates formation of complexes containing VEGFR-2 and neuropilin-1 that enhance VEGF165-receptor binding

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Neuropilin-1 expression by tumor cells promotes tumor angiogenesis and progression

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Concurrent induction of lymphangiogenesis, angiogenesis, and macrophage recruitment by vascular endothelial growth factor-C in melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

VEGF-D promotes the metastatic spread of tumor cells via the lymphatics

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Mice lacking the vascular endothelial growth factor-B gene (Vegfb) have smaller hearts, dysfunctional coronary vasculature, and impaired recovery from cardiac ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Nicotine and cotinine up-regulate vascular endothelial growth factor expression in endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Post-transcriptional regulation of vascular endothelial growth factor by hypoxia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Transforming growth factor-beta and Ras regulate the VEGF/VEGF-receptor system during tumor angiogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Human herpesvirus-8-transformed endothelial cells have functionally activated vascular endothelial growth factor/vascular endothelial growth factor receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

1,25-dihydroxyvitamin D3 stimulates vascular endothelial growth factor release in aortic smooth muscle cells: role of p38 mitogen-activated protein kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

VEGF expression and enhanced production by gonadotropins in ovarian epithelial tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Tumor necrosis factor-alpha inhibits growth factor-mediated cell proliferation through SHP-1 activation in endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Connective tissue growth factor binds vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor/vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Decreased mRNA stability as a mechanism of glucocorticoid-mediated inhibition of vascular endothelial growth factor gene expression by cultured keratinocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Angiopoietin-1 protects the adult vasculature against plasma leakage.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Angiopoietins 3 and 4: diverging gene counterparts in mice and humans

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Blood vessel formation: what is its molecular basis?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Vascular-specific growth factors and blood vessel formation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Endothelial receptor tyrosine kinases involved in angiogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

The endothelial receptor tyrosine kinase tie-1 is upregulated by hypoxia and vascular endothelial growth factor.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

The endothelial receptor tyrosine kinase Tie1 activates phosphatidylinositol 3-kinase and Akt to inhibit apoptosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Tumor angiogenesis: past, present and the near future

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Localization of basic fibroblast growth factor, a mitogen and angiogenic factor, in human brain tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Correlation of basic fibroblast growth factor expression levels with the degree of malignancy and vascularity in human gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Signals via FGF receptor 2 regulate migration of endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

bFGF and VEGF synergistically enhance endothelial cytoprotection via decay-accelerating factor induction

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Biological roles of fibroblast growth factor-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Extracellular matrix-resident growth factors and enzymes: possible involvement in tumor metastasis and angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

The ins and outs of fibroblast growth factors

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Mechanism of basic fibroblast growth factor-induced cell death

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

How matrix metalloproteinases regulate cell behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

A biological staging model for operable non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Metalloproteinases: role in breast carcinogenesis, invasion and metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumor model

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

1 reference

7 January 2021

Adhesion events in angiogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Integrin and growth factor receptor crosstalk.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

1 reference

7 January 2021

Enhanced pathological angiogenesis in mice lacking β3 integrin or β3 and β5 integrins

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Evidence for the involvement of endothelial cell integrin alphaVbeta3 in the disruption of the tumor vasculature induced by TNF and IFN-gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Extensive vasculogenesis, angiogenesis, and organogenesis precede lethality in mice lacking all alpha v integrins

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Ligands for EPH-related receptor tyrosine kinases that require membrane attachment or clustering for activity

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

The ephrin-A1 ligand and its receptor, EphA2, are expressed during tumor neovascularization

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Macrophage-derived metalloelastase is responsible for the generation of angiostatin in Lewis lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Generation of Angiostatin by Reduction and Proteolysis of Plasmin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Selective inhibition by kringle 5 of human plasminogen on endothelial cell migration, an important process in angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Angiostatin binds ATP synthase on the surface of human endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Angiomotin: an angiostatin binding protein that regulates endothelial cell migration and tube formation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

The production of cytokines by polymorphonuclear neutrophils

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Neutrophils as a key cellular target for angiostatin: implications for regulation of angiogenesis and inflammation.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Endothelial cell surface F1-F0 ATP synthase is active in ATP synthesis and is inhibited by angiostatin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Antiangiogenesis signals by endostatin.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Identification of three N-terminal ends of type XVIII collagen chains and tissue-specific differences in the expression of the corresponding transcripts. The longest form contains a novel motif homologous to rat and Drosophila frizzled proteins.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Generation and degradation of human endostatin proteins by various proteinases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Endostatin causes G1 arrest of endothelial cells through inhibition of cyclin D1.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Endostatin binds tropomyosin. A potential modulator of the antitumor activity of endostatin.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

The Angiogenesis Inhibitor, Endostatin, Does Not Affect Murine Cutaneous Wound Healing

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

The angiogenesis inhibitor endostatin impairs blood vessel maturation during wound healing.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Overexpression of ornithine decarboxylase enhances endothelial proliferation by suppressing endostatin expression

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Inhibition of angiogenesis by thrombospondin-2

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Thrombospondins: multifunctional regulators of cell interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Inducer-stimulated Fas targets activated endothelium for destruction by anti-angiogenic thrombospondin-1 and pigment epithelium-derived factor

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Tumor suppression in human skin carcinoma cells by chromosome 15 transfer or thrombospondin-1 overexpression through halted tumor vascularization

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Overexpression of thrombospondin-1 decreases angiogenesis and inhibits the growth of human cutaneous squamous cell carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Thrombospondin-2: a potent endogenous inhibitor of tumor growth and angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Thrombospondin-1-mediated metastasis suppression by the primary tumor in human melanoma xenografts

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Inhibition of tumor growth by systemic treatment with thrombospondin-1 peptide mimetics.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Antisense-mediated reduction in thrombospondin reverses the malignant phenotype of a human squamous carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Angiogenesis inhibitors as cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Clinicoprognostic implications of increased serum levels of vascular endothelial growth factor and basic fibroblastic growth factor in early B-cell chronic lymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Angiogenic growth factors and endostatin in non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

High expression of MCL1 gene related to vascular endothelial growth factor is associated with poor outcome in non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Expression of angiogenic factors predicts response to chemoradiotherapy and prognosis of oesophageal squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Role of vascular endothelial growth factor in regulation of physiological angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Heterogeneity of angiogenic activity in a human liposarcoma: a proposed mechanism for "no take" of human tumors in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Phase Ib trial of intravenous recombinant humanized monoclonal antibody to vascular endothelial growth factor in combination with chemotherapy in patients with advanced cancer: pharmacologic and long-term safety data

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Integrin alpha(v)beta(3) is involved in stimulated migration of vascular adventitial fibroblasts by basic fibroblast growth factor but not platelet-derived growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Evidence for distinct signaling properties and biological responses induced by the PDGF receptor alpha and beta subtypes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

The antiangiogenic protein kinase inhibitors SU5416 and SU6668 inhibit the SCF receptor (c-kit) in a human myeloid leukemia cell line and in acute myeloid leukemia blasts

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Effect of VEGF receptor inhibitor PTK787/ZK222584 [correction of ZK222548] combined with ionizing radiation on endothelial cells and tumour growth

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Novel 4-anilinoquinazolines with C-7 basic side chains: design and structure activity relationship of a series of potent, orally active, VEGF receptor tyrosine kinase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Pilot study of vitaxin--an angiogenesis inhibitor-in patients with advanced leiomyosarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

A pilot trial of Vitaxin, a humanized anti-vitronectin receptor (anti alpha v beta 3) antibody in patients with metastatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Up-regulation of cyclooxygenase 2 gene expression correlates with tumor angiogenesis in human colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Correlation of expression of cyclooxygenase-2, vascular endothelial growth factor, and peroxisome proliferator-activated receptor delta with head and neck squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

The role of cyclooxygenase-2 in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Expression of cyclooxygenase-2 in patients with bladder carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Reduced incidence of colorectal adenoma among long-term users of nonsteroidal antiinflammatory drugs: a pooled analysis of published studies and a new population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Aspirin use and lung, colon, and breast cancer incidence in a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

NSAIDs inhibit alpha V beta 3 integrin-mediated and Cdc42/Rac-dependent endothelial-cell spreading, migration and angiogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Celecoxib, a selective cyclo-oxygenase-2 inhibitor, enhances the response to preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Risk of cardiovascular events associated with selective COX-2 inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Systemic inhibition of tumor growth and tumor metastases by intramuscular administration of the endostatin gene

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Antiangiogenic activity of endostatin inhibits C6 glioma growth

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Adenovirus-mediated gene transfer of endostatin in vivo results in high level of transgene expression and inhibition of tumor growth and metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Continuous release of endostatin from microencapsulated engineered cells for tumor therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Methionine aminopeptidase-2 regulates human mesothelioma cell survival: role of Bcl-2 expression and telomerase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Selective inhibition of amino-terminal methionine processing by TNP-470 and ovalicin in endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

The antiangiogenic agent TNP-470 requires p53 and p21CIP/WAF for endothelial cell growth arrest

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Efficacy of antiangiogenic therapy with TNP-470 in superficial and invasive bladder cancer models in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Growth inhibition of liver metastases by the anti-angiogenic drug TNP-470.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Angiogenesis inhibitor TNP-470 reduces human pancreatic cancer growth

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Anti-angiogenic treatment for peritoneal dissemination of pancreas adenocarcinoma: a study using TNP-470.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

The inhibitory effects of TNP470 on tumour growth of head and neck carcinoma cell producing interleukin-8.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Effect of TNP-470 (AGM-1470) on the growth of rat rhabdomyosarcoma tumors of different sizes.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Prevention of fracture healing in rats by an inhibitor of angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Angiogenesis inhibitor TNP-470 inhibits murine cutaneous wound healing

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Fumagillin analog in the treatment of Kaposi's sarcoma: a phase I AIDS Clinical Trial Group study. AIDS Clinical Trial Group No. 215 Team

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Multi-institutional study of the angiogenesis inhibitor TNP-470 in metastatic renal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Thalidomide: emerging role in cancer medicine

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Results of a randomized study of IM862 nasal solution in the treatment of AIDS-related Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Antiangiogenic and antimetastatic properties of Neovastat (AE-941), an orally active extract derived from cartilage tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Organ targeting in vivo using phage display peptide libraries

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Targeting the prostate for destruction through a vascular address

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Steps toward mapping the human vasculature by phage display.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Combined effects of angiostatin and ionizing radiation in antitumour therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

The antiangiogenic agents SU5416 and SU6668 increase the antitumor effects of fractionated irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

9:00-9:15. Antiangiogenic Treatment with Endostatin Results in Uncoupling of Blood Flow and Glucose Metabolism in Human Tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Docetaxel administered on a weekly basis for metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Low-dose oral methotrexate and cyclophosphamide in metastatic breast cancer: antitumor activity and correlation with vascular endothelial growth factor levels

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Effect of p53 status on tumor response to antiangiogenic therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

Angioprevention': angiogenesis is a common and key target for cancer chemopreventive agents

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900047-3

7 January 2021

10.1016/S0889-8588(02)00047-3

Identifiers

DOI

1 reference

release_rxt64hlm2zd6dhjnk4uqwvx5ua

5 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/rxt64hlm2zd6dhjnk4uqwvx5ua

24 November 2022

mapped directly with Wikidata item

1 reference